MDSP

Computer programs relating to assays for the diagnosis of diseases, namely computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for disease states, namely computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, namely computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences, namely computer programs for accepting analysis results and for determining therefrom which biological substances are present and the structure of such biological substances; scientific instruments for developing assays for the diagnosis of diseases, and for developing chemical markers for disease states, and for performing diagnostics for diseases, and for determining targets for drugs, and for determining protein and peptide sequences, namely mass spectrometers, sample separation apparatus, sample enrichment apparatus, sample preparation apparatus, optical detectors, and micro-fluidic sample processing apparatus

Medical research, namely developing assays for the diagnosis of diseases; developing chemical markers which indicate the presence of disease states; performing diagnostics for diseases, namely analyzing and reporting on patient specimens; determining biological targets for drugs, namely determining biological processes which are susceptible to being affected by drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services, namely developing bioanalytical methods to increase the throughtput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry processes and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services and developing methods to reduce the sample sizes needed, and to increase the reliability of assays; and leasing of medical equipment, namely mass spectrometers, electrophoresis analyzers, separation apparatus, namely liquid chromatographs and capillary electrophoresis apparatus, optical detection systems, namely ultraviolet, fluorescence and chemiluminescent detectors, microfluid apparatus and sample preparation apparatus